NFKB1 and contact dermatitis: In summary, downregulation of p-IκBα levels upon treatment with ghrelin in OXA-induced contact dermatitis and IMQ-induced psoriasis mouse models indicate ghrelin’s ability to antagonize NF-κB signaling in these disorders.